These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32785205)

  • 1. Factors determining elective cardioversion preceded by transesophageal echocardiography: experiences of 2 cardiology centers.
    Uziębło-Życzkowska B; Kiliszek M; Gorczyca I; Woronowicz-Chróściel A; Bielecka B; Wałek P; Jelonek O; Wożakowska-Kapłon B; Krzesiński P
    Pol Arch Intern Med; 2020 Oct; 130(10):837-843. PubMed ID: 32785205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elective cardioversion of atrial fibrillation is safe without transesophageal echocardiography in patients treated with non-vitamin K antagonist oral anticoagulants: Multicenter experience.
    Gorczyca I; Uziębło-Życzkowska B; Szpotowicz A; Chrapek M; Krzesiński P; Bielecka B; Woronowicz-Chróściel A; Wałek P; Krzciuk M; Wożakowska-Kapłon B
    Cardiol J; 2023; 30(2):228-236. PubMed ID: 33634847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion.
    Barysienė J; Žebrauskaitė A; Petrikonytė D; Marinskis G; Aidietienė S; Aidietis A
    BMC Cardiovasc Disord; 2017 Feb; 17(1):67. PubMed ID: 28228120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is transesophageal echocardiography necessary before electrical cardioversion in patients treated with non-vitamin K antagonist oral anticoagulants? Current evidence and practical approach.
    Gorczyca I; Uziębło-Życzkowska B; Krzesiński P; Major A; Kapłon-Cieślicka A
    Cardiol J; 2023; 30(4):646-653. PubMed ID: 34671967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial.
    Kozieł M; Merino JL; De Caterina R; Huber K; Jin J; Melino M; Goette A; Lip GYH;
    Eur J Clin Invest; 2020 May; 50(5):e13221. PubMed ID: 32150758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
    Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
    Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioversion in patients with atrial fibrillation and left atrial thrombi on initial transesophageal echocardiography: should transesophageal echocardiography be repeated before elective cardioversion? A cost-effectiveness analysis.
    Seto TB; Taira DA; Manning WJ
    J Am Soc Echocardiogr; 1999 Jun; 12(6):508-16. PubMed ID: 10359923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.
    Seidl K; Rameken M; Drögemüller A; Vater M; Brandt A; Schwacke H; Bergmeier C; Zahn R; Senges J
    J Am Coll Cardiol; 2002 May; 39(9):1436-42. PubMed ID: 11985904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up.
    de Luca I; Sorino M; De Luca L; Colonna P; Del Salvatore B; Corlianò L
    Int J Cardiol; 2005 Jul; 102(3):447-54. PubMed ID: 16004890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transesophageal echocardiography before cardioversion of recurrent atrial fibrillation: does absence of previous atrial thrombi preclude the need of a repeat test?
    Shen X; Li H; Rovang K; Hee T; Holmberg MJ; Mooss AN; Mohiuddin SM
    Am Heart J; 2003 Oct; 146(4):741-5. PubMed ID: 14564332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of left atrial appendage thrombogenic milieu in patients subjected to transesophageal echocardiography prior to cardioversion of persistent atrial fibrillation.
    Jaroch J; Kamińska-Kegel A; Brzezińska B; Kruszyńska E; Bociąga Z; Dudek K; Łoboz-Grudzień K
    Pol Arch Med Wewn; 2016; 126(1-2):25-31. PubMed ID: 26811148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: a pilot study.
    Cohen A; Stellbrink C; Le Heuzey JY; Faber T; Aliot E; Banik N; Kropff S; Omran H;
    Arch Cardiovasc Dis; 2015 Feb; 108(2):122-31. PubMed ID: 25684570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a clinical trial for the assessment of cardioversion using transesophageal echocardiography (The ACUTE Multicenter Study). Steering and Publications Committees of the ACUTE Study.
    Am J Cardiol; 1998 Apr; 81(7):877-83. PubMed ID: 9555778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ineffective anticoagulation prior to elective electric cardioversion for atrial fibrillation. Results of transesophageal echocardiography].
    Stopp M; Kristen C; Sybrecht GW; Jung J
    Dtsch Med Wochenschr; 2003 Jun; 128(23):1277-81. PubMed ID: 12789636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study.
    Kim YG; Choi JI; Kim MN; Cho DH; Oh SK; Kook H; Park HS; Lee KN; Baek YS; Roh SY; Shim J; Park SM; Shim WJ; Kim YH
    PLoS One; 2018; 13(1):e0191648. PubMed ID: 29360845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K Antagonists Versus Novel Oral Anticoagulants for Elective Electrical Cardioversion of Atrial Fibrillation.
    Ţînţ D; Petriş AO; Pop I; Melnic R; Ignat AM; Rogozea LM
    Am J Ther; 2017; 24(5):e553-e558. PubMed ID: 28661896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion.
    Itäinen S; Lehto M; Vasankari T; Mustonen P; Kotamäki M; Numminen A; Lahtela H; Bah A; Hartikainen J; Hekkala AM; Airaksinen JKE
    Europace; 2018 Apr; 20(4):565-568. PubMed ID: 29016758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of transesophageal echocardiography‑guided electrical cardioversion in patients with atrial fibrillation and inadequate anticoagulation.
    Zaprutko J; Baszko A; Michalak M; Kochman K; Szymański R; Kłopocki J; Nowicka A; Dankowski R; Michalski M; Kałmucki P; Szyszka A
    Pol Arch Intern Med; 2017 Aug; 127(7-8):524-531. PubMed ID: 28817542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography.
    Klein AL; Grimm RA; Black IW; Leung DY; Chung MK; Vaughn SE; Murray RD; Miller DP; Arheart KL
    Ann Intern Med; 1997 Feb; 126(3):200-9. PubMed ID: 9027270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.